Biomea Fusion Inc (BMEA)
8.89
+0.05
(+0.57%)
USD |
NASDAQ |
Nov 05, 16:00
8.89
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Research and Development Expense (Annual): 102.55M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 102.55M |
| December 31, 2022 | 62.71M |
| December 31, 2021 | 28.00M |
| Date | Value |
|---|---|
| December 31, 2020 | 3.671M |
| December 31, 2019 | 1.092M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.092M
Minimum
2019
102.55M
Maximum
2023
39.60M
Average
28.00M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Clearside Biomedical Inc | 20.85M |
| Crinetics Pharmaceuticals Inc | 168.53M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |